Accessibility Menu
Siemens Healthineers Ag Stock Quote

Siemens Healthineers Ag (OTC: SMMNY)

$28.48
(1.2%)
+0.34
Price as of October 22, 2025, 1:13 p.m. ET

KEY DATA POINTS

Current Price
$28.48
Daily Change
(1.2%) +$0.34
Day's Range
$28.39 - $28.64
Previous Close
$28.14
Open
$28.4
Beta
0.76
Volume
13,614
Average Volume
65,263
Market Cap
63.1B
Market Cap / Employee
$28.14M
52wk Range
$23.28 - $30.19
Revenue
-
Gross Margin
0.39%
Dividend Yield
1.76%
EPS
$1.05
CAPs Rating
-
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Siemens Healthineers Ag Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
SMMNY+1.92%+35.53%+6.27%+49%
S&P+15.06%+95.03%+14.29%+147%

Siemens Healthineers Ag Company Info

Siemens Healthineers AG operates as a holding company. The company intends to operate the digital services business. It operates through the following business segments: Imaging, Diagnotics, and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. The company was founded on December 1, 2017 and is headquartered in Erlangen, Germany.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$6.42B10.0%
Gross Profit$2.47B10.0%
Gross Margin38.52%0.0%
Market Cap$62.22B-3.0%
Market Cap / Employee$0.85M-5.2%
Employees73.5K2.4%
Net Income$630.69M24.1%
EBITDA$1.41B33.1%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$2.79B26.5%
Accounts Receivable$7.15B11.3%
Inventory5.2K2.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$13.68B-11.5%
Short Term Debt$4.75B81.7%

Ratios

Q2 2025YOY Change
Return On Assets4.63%0.6%
Return On Invested Capital6.50%-1.1%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$836.22M54.0%
Operating Free Cash Flow$1.05B41.4%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Earnings31.8927.6026.7326.19-18.15%
Price to Book3.432.902.933.09-3.18%
Price to Sales2.782.442.432.45-9.39%
Price to Tangible Book Value-8.75-8.09-9.54-8.870.19%
Price to Free Cash Flow TTM87.7842.74236.1637.05-92.32%
Enterprise Value to EBITDA47.4367.1759.9055.31-27.21%
Free Cash Flow Yield1.1%2.3%0.4%2.7%1202.58%
Return on Equity10.7%10.7%11.1%11.8%11.66%
Total Debt$18.09B$17.21B$18.21B$18.43B1.98%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.